MISHA™
-
Top Stories
Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States
Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement Multiple…
Read More » -
Regulatory
FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis
Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement MISHA…
Read More » -
Sports Medicine
Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
Implantable shock absorber demonstrates clinically meaningful pain relief and functional improvement in data presented at OSET September 23, 2022 FREMONT,…
Read More » -
Sports Medicine
Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis
August 16, 2022 FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for…
Read More »